Abstract
A novel potent and selective kynurenine-3-hydroxylase inhibitor is descibed along a preliminary evaluation in a in vivo gerbil model of its ability to increase the kynurenine and kynurenic acid concentration in both plasma and brain. These data support the notion that kynurenine-3-hydroxylase inhibitors may have a sustained therapeutic potential in those diseases characterized by unbalance in the QUIN /KYNA branches of the kynurenine pathway.
| Original language | English |
|---|---|
| Pages (from-to) | 621-628 |
| Number of pages | 8 |
| Journal | Advances in Experimental Medicine and Biology |
| Volume | 527 |
| Publication status | Published - 2003 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase. / Pellicciari, Roberto; Amori, Laura; Costantino, Gabriele; Giordani, Antonio; Macchiarulo, Antonio; Mattoli, Luisa; Pevarello, Paolo; Speciale, Carmela; Varasi, Mario.
In: Advances in Experimental Medicine and Biology, Vol. 527, 2003, p. 621-628.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase
AU - Pellicciari, Roberto
AU - Amori, Laura
AU - Costantino, Gabriele
AU - Giordani, Antonio
AU - Macchiarulo, Antonio
AU - Mattoli, Luisa
AU - Pevarello, Paolo
AU - Speciale, Carmela
AU - Varasi, Mario
PY - 2003
Y1 - 2003
N2 - A novel potent and selective kynurenine-3-hydroxylase inhibitor is descibed along a preliminary evaluation in a in vivo gerbil model of its ability to increase the kynurenine and kynurenic acid concentration in both plasma and brain. These data support the notion that kynurenine-3-hydroxylase inhibitors may have a sustained therapeutic potential in those diseases characterized by unbalance in the QUIN /KYNA branches of the kynurenine pathway.
AB - A novel potent and selective kynurenine-3-hydroxylase inhibitor is descibed along a preliminary evaluation in a in vivo gerbil model of its ability to increase the kynurenine and kynurenic acid concentration in both plasma and brain. These data support the notion that kynurenine-3-hydroxylase inhibitors may have a sustained therapeutic potential in those diseases characterized by unbalance in the QUIN /KYNA branches of the kynurenine pathway.
UR - http://www.scopus.com/inward/record.url?scp=1042279498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1042279498&partnerID=8YFLogxK
M3 - Article
C2 - 15206781
AN - SCOPUS:1042279498
VL - 527
SP - 621
EP - 628
JO - Advances in Experimental Medicine and Biology
JF - Advances in Experimental Medicine and Biology
SN - 0065-2598
ER -